Pressure-Volume Loop #2: Inotropy, Contractility, and Afterload

1. Introduction

The ventricular pressure–volume (PV) loop provides a mechanical framework for understanding how intrinsic contractile performance and arterial loading determine ventricular ejection. Its principal advantage is that it separates changes in contractility from changes in preload and afterload, which can produce similar alterations in stroke volume or ejection fraction through different mechanisms. The accompanying diagrams illustrate three responses: increased inotropy, reduced contractility, and increased afterload [1].

These relationships are particularly useful when interpreting low cardiac output, vasoactive drug responses, acute ventricular dysfunction, or hemodynamic changes after cardiac surgery. The diagrams are idealized left ventricular loops. In clinical practice, heart rate, filling conditions, ventricular geometry, valve function, and the arterial circulation frequently change together.

2. Mechanical Foundations

2.1. The four phases and two reference relationships

The horizontal axis represents ventricular volume; the vertical axis represents ventricular pressure. A normal loop proceeds counterclockwise through diastolic filling, isovolumetric contraction, systolic ejection, and isovolumetric relaxation. Its horizontal width is stroke volume:

SV = EDV − ESV

Here, EDV is end-diastolic volume and ESV is end-systolic volume. Ejection fraction (EF = SV/EDV) describes the fraction of chamber volume ejected but is not an isolated measure of intrinsic contractility [1].

Two relationships provide the mechanical context:

• End-systolic pressure–volume relationship (ESPVR): Describes the relationship between end-systolic pressure and volume across different loading conditions.
• End-diastolic pressure–volume relationship (EDPVR): Describes passive chamber filling properties and determines the diastolic pressure associated with a given ventricular volume.

A conventional linear approximation of ESPVR is:

Pes ≈ Ees × (ESV − V0)

Pes is end-systolic pressure, Ees is end-systolic elastance (the slope of ESPVR), and V0 is its extrapolated volume-axis intercept. The classical time-varying elastance model established Ees as an index of chamber contractile state that is substantially less load dependent than EF or stroke volume [2,3]. It is not perfectly load independent and is influenced by chamber size, geometry, and the range over which it is measured.

2.2. What changes a loop?

An intervention may change the position of the operating point along an existing relationship or change the relationship itself. Increasing preload primarily moves the end-diastolic point along the EDPVR. Changing inotropy alters the ESPVR. Changing arterial load shifts the end-systolic operating point through the interaction between the ventricle and arterial system.

This distinction is essential: a change in stroke volume does not necessarily indicate a change in contractility.

3. Increased Inotropy: A Steeper ESPVR

3.1. Mechanical response

Inotropy denotes the intrinsic contractile state of myocardium. A positive inotropic intervention increases the capacity to develop force and eject blood at a given loading condition. On an idealized PV diagram, the ESPVR becomes steeper, reflecting increased end-systolic elastance.

With preload and arterial loading otherwise held constant, increased inotropy generally produces:

• Decreased ESV: More complete ventricular emptying.
• Increased stroke volume and EF: Greater ejection from approximately the same EDV.
• Increased potential to generate systolic pressure: The ventricle can sustain a higher pressure at a specified volume.
• A leftward shift of the end-systolic point: The loop becomes wider.

Experiments using pressure–volume analysis showed that pharmacologic enhancement of contractility, including dobutamine administration, increases measured end-systolic elastance [3,4].

The slide depicts a higher systolic loop and a reduced ESV. The key observation is the steeper ESPVR, not the absolute height of the pressure trace. Actual peak systolic pressure may increase, remain similar, or even fall when an inotropic agent simultaneously reduces vascular resistance or changes flow.

3.2. Pharmacologic interpretation

Beta-adrenergic agonists such as dobutamine principally increase inotropy through intracellular calcium signaling, although effects on heart rate and vascular tone complicate the response. Milrinone, a phosphodiesterase-3 inhibitor, combines positive inotropy with systemic and pulmonary vasodilation. Its hemodynamic effects therefore cannot be represented solely by rotating the ESPVR: it may also reduce the effective arterial load.

A wider PV loop after administration of an inodilator could reflect increased Ees, decreased arterial load, improved filling, or a combination. The observed change in EF should not be attributed automatically to improved intrinsic myocardial function. Furthermore, the ESPVR may depart from strict linearity across a broad range of loading conditions [5].

4. Reduced Contractility: A Flatter ESPVR

4.1. Immediate systolic consequences

Depressed intrinsic contractility produces the opposite mechanical response. The ESPVR becomes flatter, indicating lower end-systolic elastance. With preload and afterload held constant, the ventricle ejects less effectively, so ESV increases and stroke volume decreases. The loop becomes narrower, and EF usually falls [3].

Reduced contractility can result from myocardial ischemia, inflammation, cardiomyopathy, inadequate myocardial protection, or postoperative myocardial stunning. The PV loop describes the hemodynamic consequence; it cannot establish the underlying cause.

4.2. Compensation and congestion

Over subsequent beats, incomplete emptying may increase residual ventricular volume and contribute to a higher EDV if venous return and filling conditions permit. This can partially preserve stroke volume through the Frank–Starling mechanism. However, movement to a higher volume along the EDPVR may increase filling pressure and predispose to pulmonary or systemic venous congestion.

Ventricular dilation and increased end-diastolic pressure are potential secondary responses, not necessary components of an acute decrease in contractility. A patient may have depressed systolic function with limited dilation, particularly in acute myocardial dysfunction or when ventricular filling is restricted.

Conversely, a volume-loaded ventricle may demonstrate a relatively preserved EF despite important myocardial impairment. This is why serial interpretation must consider preload reserve and the relationship between contractility and arterial load [6].

5. Increased Afterload: A Taller, Narrower Loop

5.1. The definition of afterload

Afterload is the mechanical load opposing ventricular shortening and ejection. Clinically, it depends on ventricular pressure, arterial pressure and impedance, outflow obstruction, wall geometry, and systolic wall stress. It is not synonymous with systemic vascular resistance or a single arterial blood pressure value.

In the simplified PV model, arterial load is represented by effective arterial elastance (Ea):

Ea ≈ Pes / SV

Ea has units of pressure per volume and is often drawn as the magnitude of a downward-sloping line connecting the end-diastolic volume on the volume axis to the end-systolic operating point. Its orientation is different from the upward-sloping ESPVR. Human studies established its practical usefulness for describing ventricular loading [7].

5.2. Response to increased load

When afterload rises abruptly and intrinsic contractility and initial EDV remain fixed, the ventricle must develop greater pressure to eject against the circulation. Its end-systolic operating point moves upward and rightward along the same ESPVR. The characteristic response is:

• Higher end-systolic pressure.
• Higher ESV.
• Lower stroke volume and EF.
• A taller, narrower PV loop.

The underlying ESPVR does not need to change. Thus, an apparent reduction in systolic performance may reflect afterload mismatch rather than primary myocardial depression. Ross's framework of afterload mismatch explains why a sudden rise in arterial load can sharply reduce ejection, especially when contractile or preload reserve is limited [6].

The longer-term response may differ: sympathetic activation, ventricular filling, and myocardial remodeling can alter EDV, Ees, and chamber geometry. In severe ventricular failure, the circulation may be unable to sustain a higher arterial pressure despite increased vascular resistance.

6. Ventricular–Arterial Coupling

6.1. Interaction between Ees and Ea

The ventricle and arterial circulation function as a coupled mechanical system. Ees describes chamber end-systolic properties, whereas Ea provides a simplified representation of the arterial load presented to that chamber. Their ratio, Ea/Ees, is widely used to assess ventricular–arterial coupling [8,9].

In a linear approximation:

SV ≈ Ees × (EDV − V0) / (Ees + Ea)

This expression makes the competing effects explicit. Increasing Ees tends to increase stroke volume; increasing Ea tends to reduce it when other variables are unchanged. A weak ventricle facing substantial arterial load may consequently have a markedly narrower loop than either abnormality alone would suggest.

The ratio should not be interpreted as a universal target. Both Ees and Ea may be abnormal while their ratio remains apparently normal. Moreover, optimal coupling for mechanical efficiency is not necessarily identical to coupling for maximal stroke work, and these objectives vary with physiological conditions [9,11].

6.2. Limitations of effective arterial elastance

Although Ea is useful at the ventricular operating point, it does not directly measure every component of pulsatile afterload. A human study found that much of its variability was explained by vascular resistance and heart rate, while it was relatively insensitive to independent changes in pulsatile arterial load [10].

Therefore, Ea should not replace detailed assessment of arterial compliance, wave reflections, vascular impedance, or fixed outflow obstruction when these features materially affect clinical decisions.

7. Clinical and Perioperative Applications

7.1. Interpreting low cardiac output

When a patient develops low cardiac output, three different mechanisms may generate a narrow PV loop: insufficient preload, depressed contractility, and excessive afterload. Treatment differs substantially.

Predominant contractile impairment may justify inotropic support after excluding inadequate filling, ischemia, arrhythmia, and important residual lesions. Predominant afterload mismatch may respond to appropriately selected vasodilator therapy if perfusion pressure can be maintained. Inadequate filling requires evaluation of venous return, diastolic pressure, ventricular compliance, and ventricular interaction rather than automatic administration of fluid.

A mixed physiological disturbance is common. Increasing inotropy while leaving severe obstruction untreated, or reducing afterload in a patient with profound vasoplegia, may fail to improve effective systemic perfusion.

7.2. Postoperative pediatric cardiac care

Following congenital heart surgery, myocardial stunning, altered systemic or pulmonary vascular resistance, loading changes from residual shunts, and atrioventricular valve regurgitation can affect observed ventricular performance.

The pediatric PRIMACORP randomized trial reported a reduction in low cardiac output syndrome with high-dose prophylactic milrinone compared with placebo in selected high-risk patients after corrective surgery [12]. However, a subsequent Cochrane review found that the available trials were insufficient to establish reliable effects on mortality and several other major outcomes [13]. These findings support physiological consideration of inodilator therapy without implying that a particular PV-loop pattern mandates a specific drug.

A rise in arterial pressure after vasopressor administration does not guarantee increased cardiac output. If increased Ea outweighs any improvement in coronary perfusion or Ees, stroke volume may fall. Conversely, reducing excessive arterial load can increase output even without an immediate improvement in intrinsic contractility.

7.3. Ventricular geometry and complex circulation

The conventional LV model requires caution when applied to the right ventricle, a systemic right ventricle, single-ventricle circulations, or ventricles with substantial outflow obstruction. Ventricular morphology, interventricular interaction, and pulmonary or systemic vascular loading may differ considerably.

In significant valve regurgitation or intracardiac shunting, the loop width reflects total ventricular volume change, not necessarily effective forward systemic stroke volume. An apparently satisfactory EF may coexist with poor systemic delivery. Clinical assessment must therefore integrate forward flow, arterial pressure, filling pressures, oxygen delivery, echocardiography, and the relevant postoperative anatomy.

8. Measurement and Interpretation

Direct PV-loop measurement requires synchronized pressure and volume data, generally through invasive instrumentation. Estimation of ESPVR typically involves multiple beats obtained during a transient change in loading conditions; conductance-catheter studies demonstrated the feasibility of this approach [4].

Several qualifications are important:

• The ESPVR is not invariably linear. Nonlinearity and apparent load sensitivity have been demonstrated across wide physiological ranges [5].
• Single-beat Ees estimates are model dependent. They should not be confused with a directly measured multi-beat slope.
• Peak pressure differs from end-systolic pressure. Substituting one for the other introduces approximation.
• Heart rate, rhythm, valve lesions, and ventricular interaction matter. They affect the measured loop and its interpretation.

PV analysis is primarily a physiological interpretive framework, not a routine standalone bedside decision tool. Its greatest value lies in identifying whether a change in stroke volume plausibly arises from altered contractility, altered arterial loading, or altered filling.

9. Key Clinical Principles

• Increased inotropy: Steeper ESPVR, lower ESV, and usually greater stroke volume at unchanged loading conditions.
• Reduced contractility: Flatter ESPVR, higher ESV, and lower stroke volume; dilation and increased EDP may develop secondarily.
• Increased afterload: Higher end-systolic pressure and ESV, producing a taller, narrower loop without requiring a change in Ees.
• Ees and Ea describe different properties: Ees characterizes the ventricle; Ea approximates its effective arterial load.
• EF is load dependent: It must not be interpreted as a pure index of contractility.
• Therapy should address the mechanism: Inotropy, arterial loading, preload, and residual structural lesions must be considered together.

References

1. Burkhoff D. Pressure-volume loops in clinical research: a contemporary view. J Am Coll Cardiol. 2013;62:1173–1176. DOI: 10.1016/j.jacc.2013.05.049. PMID: 23770176.
2. Suga H, Sagawa K, Shoukas AA. Load independence of the instantaneous pressure-volume ratio of the canine left ventricle and effects of epinephrine and heart rate on the ratio. Circ Res. 1973;32:314–322. DOI: 10.1161/01.RES.32.3.314. PMID: 4691336.
3. Kass DA, Maughan WL, Guo ZM, Kono A, Sunagawa K, Sagawa K. Comparative influence of load versus inotropic states on indexes of ventricular contractility: experimental and theoretical analysis based on pressure-volume relationships. Circulation. 1987;76:1422–1436. DOI: 10.1161/01.CIR.76.6.1422. PMID: 3454658.
4. Kass DA, Yamazaki T, Burkhoff D, Maughan WL, Sagawa K. Determination of left ventricular end-systolic pressure-volume relationships by the conductance (volume) catheter technique. Circulation. 1986;73:586–595. DOI: 10.1161/01.CIR.73.3.586. PMID: 2868811.
5. van der Velde ET, Burkhoff D, Steendijk P, Karsdon J, Sagawa K, Baan J. Nonlinearity and load sensitivity of end-systolic pressure-volume relation of canine left ventricle in vivo. Circulation. 1991;83:315–327. DOI: 10.1161/01.CIR.83.1.315. PMID: 1670628.
6. Ross J Jr. The concept of afterload mismatch and its implications in the clinical assessment of cardiac contractility. Jpn Circ J. 1976;40:865–875. DOI: 10.1253/JCJ.40.865. PMID: 966366.
7. Kelly RP, Ting CT, Yang TM, et al. Effective arterial elastance as index of arterial vascular load in humans. Circulation. 1992;86:513–521. DOI: 10.1161/01.CIR.86.2.513. PMID: 1638719.
8. Asanoi H, Sasayama S, Kameyama T. Ventriculoarterial coupling in normal and failing heart in humans. Circ Res. 1989;65:483–493. DOI: 10.1161/01.RES.65.2.483. PMID: 2752553.
9. Chantler PD, Lakatta EG, Najjar SS. Arterial-ventricular coupling: mechanistic insights into cardiovascular performance at rest and during exercise. J Appl Physiol. 2008;105:1342–1351. DOI: 10.1152/japplphysiol.90600.2008. PMID: 18617626.
10. Chirinos JA, Rietzschel ER, Shiva-Kumar P, et al. Effective arterial elastance is insensitive to pulsatile arterial load. Hypertension. 2014;64:1022–1031. DOI: 10.1161/HYPERTENSIONAHA.114.03696. PMID: 25069668.
11. Ikonomidis I, Aboyans V, Blacher J, et al. The role of ventricular–arterial coupling in cardiac disease and heart failure: assessment, clinical implications and therapeutic interventions. Eur J Heart Fail. 2019;21:402–424. DOI: 10.1002/ejhf.1436. PMID: 30859669.
12. Hoffman TM, Wernovsky G, Atz AM, et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation. 2003;107:996–1002. DOI: 10.1161/01.CIR.0000051365.81920.28. PMID: 12600913.
13. Burkhardt BEU, Rücker G, Stiller B. Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart disease. Cochrane Database Syst Rev. 2015;(3):CD009515. DOI: 10.1002/14651858.CD009515.pub2. PMID: 25806562.